Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug;201(8):857-858.
doi: 10.1007/s00066-025-02429-5. Epub 2025 Jun 17.

[Stereotactic radiotherapy in functionally inoperable but technically resectable pancreatic cancer]

[Article in German]
Gunther Klautke  1
Affiliations

[Stereotactic radiotherapy in functionally inoperable but technically resectable pancreatic cancer]

[Article in German]
Gunther Klautke. Strahlenther Onkol. 2025 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Interessenkonflikt: G. Klautke gibt an, dass kein Interessenkonflikt besteht.

Similar articles

See all similar articles

References

Literatur

    1. Reyngold M, Schoenfeld JD, O`Reilly EM et al (2025) Nonoperative management of Technically Resectable Pancreatic Cancer With Ablative Radiation Therapy. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2025.0460 - DOI - PubMed
    1. Lin T, Reddy A, Hill C et al (2023) The Timing of Surgery Following Stereotactic Body Radiation Therapy Impacts Local Control for Borderline Resectable or Locally Advanced Pancreatic Cancer. Cancers 15:1252. https://doi.org/10.3390/cancers15041252 - DOI - PubMed - PMC
    1. Oettle H, Neuhaus P, Hochhaus A et al (2013) Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer The CONCO-001 Randomized Trial. JAMA Oncol 310:1473–1481
    1. Conroy T, Castan F, Lopez A et al (2022) Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as adjuvant Therapy for Pancreatic Cancer. A Randomized Clinical Trial. JAMA Oncol 8:1571–1578 - PubMed - PMC
    1. Birrer D, Golcher H, Casadei R et al (2021) Neoadjuvant Therapy for Resectable Pancreatic Cancer: A New Standard of Care. Poolled Data From 3 Randomized Controlled Trials. Ann Surg 274:713–720 - PubMed

LinkOut - more resources